Skip to content
10-Q

Quarterly Report

Q BIOMED INC.

0001104659-21-126758

← back to feed
Filed
Oct 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 13, 2021 28.6M sh
Cash And Equivalents Q3 2021 · Aug 31, 2021 $151.21K
Cash And Equivalents Q3 2021 · Nov 30, 2020 $177.15K
Cash And Equivalents Q3 2021 · Aug 31, 2020 $1.33M
Cash And Equivalents Q3 2021 · Nov 30, 2019 $172.64K
Current Liabilities Q3 2021 · Aug 31, 2021 $3.6M
Current Liabilities Q3 2021 · Nov 30, 2020 $1.7M
Total Liabilities Q3 2021 · Aug 31, 2021 $3.6M
Total Liabilities Q3 2021 · Nov 30, 2020 $1.7M
Current Assets Q3 2021 · Aug 31, 2021 $239.06K
Current Assets Q3 2021 · Nov 30, 2020 $223.48K
Total Assets Q3 2021 · Aug 31, 2021 $601.56K
Total Assets Q3 2021 · Nov 30, 2020 $623.48K
Shares Diluted Q3 2021 · Aug 31, 2020 22.43M sh
Shares Diluted Q3 2021 · Aug 31, 2020 21.73M sh
Operating Cash Flow Q3 2021 · Aug 31, 2020 −$4.76M
Stockholders Equity Q3 2021 · Aug 31, 2020 $126.61K
Stockholders Equity Q3 2021 · May 31, 2020 $2.11M
Stockholders Equity Q3 2021 · Nov 30, 2019 −$5.05M
Eps Diluted Q3 2021 · Aug 31, 2020 −$0.11
Eps Diluted Q3 2021 · Aug 31, 2020 −$0.50
Eps Basic Q3 2021 · Aug 31, 2020 −$0.11
Eps Basic Q3 2021 · Aug 31, 2020 −$0.50
Rd Expense Q3 2021 · Aug 31, 2020 $613.71K
Rd Expense Q3 2021 · Aug 31, 2020 $896.91K
Net Income Q3 2021 · Aug 31, 2020 −$2.26M
Net Income Q3 2021 · Aug 31, 2020 −$10.06M
Gross Profit Q3 2021 · Aug 31, 2020 −$143.52K
Gross Profit Q3 2021 · Aug 31, 2020 −$163.21K
Cost Of Revenue Q3 2021 · Aug 31, 2020 $158.52K
Cost Of Revenue Q3 2021 · Aug 31, 2020 $193.21K
Revenue Q3 2021 · Aug 31, 2020 $15K
Revenue Q3 2021 · Aug 31, 2020 $30K